This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Teva Pharmaceutical Industries Ltd.
Drug Names(s): Fluticasone Propionate Spiromax, Fluticasone Propionate MDPI
Description: Fluticasone MDPI is a new formulation using Teva's multi-dose powder inhaler device, with an enhanced lung delivery that is designed to allow lower doses to achieve the same clinical outcomes as Flovent Diskus.
Fluticasone MDPI News
Additional information available to subscribers only: